Program
What is our Symposium about
- We promote interdisciplinary conversations and strengthen research network.
- We identify new pathogenic targets, biomarkers, and intricate signallingpathways to provide a comprehensive perspective on disease pathogenesis.
- We propose and pioneer new therapeutic strategies.
Preliminary Program
| 12:00 p.m. – 2:00 p.m. | Welcome Address / Lunch + Poster I / Industry I |
| 2:00 p.m. – 4:50 p.m. | Session I: Autoimmune Disease and the Role of Autoantibodies Chair: N.N. |
| 2:00 p.m. – 2:10 p.m. | Welcome UzL Präsidium |
| 2:10 p.m. – 2:40 p.m. | Keynote: Concepts of autoimmunity Prof. Dr. Y. Shoenfeld |
| 2:40 p.m. – 3:00 p.m. | GPCR abs Network in autoimmune and chronic inflammatory diseases Prof. Dr. G. Riemekasten |
| 3:00 p.m. – 3:20 p.m. | Antibodies targeting GPCR in health and disease Prof. Dr. O. Cabral-Marques (remote) |
| 3:35 p.m. – 4:50 p.m. | GPCR abs as biomarker in SSc Dr. S. Schinke |
| 4:50 p.m. – 5:10 p.m. | Coffee Break |
| 5:10 p.m. – 6:10 p.m. | Session II: Autoantibody-Induced Disease Mechanisms Chair: N.N. |
| 5:10 p.m. – 5:25 p.m. | GPCR abs as allosteric modulators, Vasculopathy Dr. D. Veprintsev |
| 5:25 p.m. – 5:40 p.m. | GPCR-Directed Autoantibodies in Glomerular Diseases: Toward Novel Biomarkers and Precision Nephrology Prof. Dr. M. Banasik |
| 5:40 p.m. – 5:55 p.m. | GPCR abs in early SSc Dr. J. Ohmes |
| 5:55 p.m. – 6:10 p.m. | Abs-mediated angiotensin II type 1 receptor activation induces endothelial dysfunction in SSc MD Cand. M. Jäpel / PD Dr. R. Akbarzadeh |
| 9:00 a.m. – 11:00 a.m. | Session III: Organ-Specific Autoantibody Pathology Chair: N.N. |
| 9:00 a.m. – 9:15 a.m. | Pathogenic and regulatory autoantibodies in MS, NMOSD and MOGAD Prof. Dr. F. Paul |
| 9:15 a.m. – 9:30 a.m. | Cardiovascular disease (CVD) Prof. Dr. T. Zeller |
| 9:30 a.m. – 9:45 a.m. | Keratinocyte-targeting functional autoantibodies in systemic sclerosis are associated with interstitial lung disease Prof. Dr. X. Yu / Dr. J. Wax |
| 9:45 a.m. – 10:00 a.m. | Complement 5a receptor-targeting antibodies and their relevance in vasculitis beyond AAV Dr. S. Klapa |
| 10:00 a.m. – 10:15 a.m. | GPCR abs in transplantation Dr. G. Moll |
| 10:15 a.m. – 10:30 a.m. | GPCR abs in RA D. Oviedo |
| 10:30 a.m. – 10:45 a.m. | Abs-driven disease severity in PsA MD Cand. L. Berg / Dr. H. Grasshoff |
| 10:45 a.m. – 11:00 a.m. | Coagulation beyond clotting: the clot thickens – regulation of organ function by coagulation protease signalling Prof. Dr. B. Isermann |
| 11:00 a.m. – 11:45 a.m. | Extended Coffee Break, Industry II and Poster Session II |
| 11:45 a.m. – 1:35 p.m. | Session IV: Autoantibodies in Fatigue and Neurological Disorders Chair: N.N. |
| 11:45 a.m. – 12:05 p.m. | ME/CFS – the role of autoimmunity and antibody-targeting therapies Prof. Dr. C. Scheibenbogen |
| 12:05 p.m. – 12:20 p.m. | Specific Antibodies and Antigens in Post-COVID and ME/CFS Dr. F. Sotzny |
| 12:20 p.m. – 12:35 p.m. | ME/CFS, a neurodegenerative autoimmune disease? Dr. A. Hackel |
| 12:35 p.m. – 12:50 p.m. | STU Talk: From Autoantibodies to Gene Expression: IgG-Mediated Transcriptome Changes in ME/CFS MSc. M. Mennenga / Dr. A. Hackel |
| 12:50 p.m. – 1:05 p.m. | The brain endothelial GPCR signaling as link between autoimmune diseases and cognitive impairment PD Dr. J. Wenzel |
| 1:05 p.m. – 1:20 p.m. | STU Talk: Functional Autoantibody Alterations Across the Lifespan in ME/CFS BSc. M. Vollert / Dr. A. Hackel |
| 1:20 p.m. – 1:35 p.m. | Expert panel: Clinical translation |
| 1:35 p.m. – 2:45 p.m. | Lunch, Poster Session III and Industry III |
| 2:45 p.m. – 5:10 p.m. | Session V: Precision Medicine & Diagnostics Chair: N.N. |
| 2:45 p.m. – 3:05 p.m. | Keynote: Abs–GPCRs, Mechanism behind Prof. Dr. T. Sakmar |
| 3:05 p.m. – 3:20 p.m. | C5aR1 abs in Chronic Inflammatory Diseases (CD) Prof. Dr. L. Björkman |
| 3:20 p.m. – 3:35 p.m. | Gold-enabled high-resolution tracking of GPCR abs binding MSc. Katja Werner |
| 3:35 p.m. – 3:50 p.m. | Combining Optical Technology with abs, SSc, PsA Dr. H. Grasshoff |
| 4:05 p.m. – 4:20 p.m. | GPCR abs: Function is key Dr. A. Hackel |
| 4:20 p.m. – 4:40 p.m. | Coffee Break |
| 4:40 p.m. – 4:55 p.m. | Distinct extracellular vesicle signatures association with GPCR abs in SSc PhD Cand. P. Bonney |
| 4:55 p.m. – 5:10 p.m. | Functional Autoantibody Responses Identify Distinct ILD Patient Phenotypes MD Cand. L. Schnoor / Dr. A. Hackel |
| 5:10 p.m. – 5:25 p.m. | Closing panel: Future directions |
| 5:25 p.m. – 5:55 p.m. | Farewell |